A phase 2 evaluation of 1-(2-chloroethyl)-3-(4- methylcyclohexyl)-1-nitrosourea (NSC 95441) in patients with advanced breast cancer.
作者信息
Ahmann D L, Bisel H F, Hahn R G
出版信息
Cancer Res. 1974 Jan;34(1):27-30.
PMID:4809462
Abstract
摘要
相似文献
1
A phase 2 evaluation of 1-(2-chloroethyl)-3-(4- methylcyclohexyl)-1-nitrosourea (NSC 95441) in patients with advanced breast cancer.
Cancer Res. 1974 Jan;34(1):27-30.
2
Evaluation of 1-(2-chloroethyl-3-4-methylcyclohexyl)-1-nitrosourea (methyl-CCNU, NSC 95441) versus combined imidazole carboxamide (NSC 45338) and vincristine (NSC 67574) in palliation of disseminated malignant melanoma.
Cancer. 1974 Mar;33(3):615-8. doi: 10.1002/1097-0142(197403)33:3<615::aid-cncr2820330304>3.0.co;2-f.
3
4
Sequential 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and 5-fluorouracil (NSC 19893) therapy of gastrointestinal cancer.
Cancer Res. 1972 Jun;32(6):1280-2.
5
The phase II study: some reflections, particularly concerning disseminated breast cancer.
Cancer Chemother Rep 3. 1972 May;3(1):29-32.
6
Combination chemotherapy for disseminated carcinoma of the breast.
Bol Asoc Med P R. 1975 Jun;67(6):157-63.
7
8
Therapy of advanced gastrointestinal cancer with the nitrosoureas.
Cancer Chemother Rep 3. 1973 May;4(3):27-34.
9
[Cytostatic treatment of metastasizing breast cancer. A prospective controlled comparison between single drug and multiple drug chemotherapy].
Ugeskr Laeger. 1977 Oct 31;139(44):2632-5.
10
Controlled evaluation of adriamycin (NSC-123127) in patients with disseminated breast cancer.
Cancer Chemother Rep. 1974 Nov-Dec;58(6):877-82.
引用本文的文献
1
Single agent versus combination chemotherapy for metastatic breast cancer.
Cochrane Database Syst Rev. 2009 Apr 15;2009(2):CD003372. doi: 10.1002/14651858.CD003372.pub3.
Zotero 插件